TCRX Tscan Therapeutics Inc

P/E --
Forward P/E --
Price/Sales 6.96
Beta 1.072
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Tscan Therapeutics Inc is trading 5.3% up today amid broad risk-on sentiment following a U.S.–Iran peace agreement

Tscan Therapeutics Inc is trading 5.3% up at $0.96 in pre-market action, tracking a broad risk-on tone in U.S. equity futures as markets react to geopolitical...